MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$199,878K
Net Income
-$15,051K
Net Profit Margin
-7.53%
EPS
-$0.46
Unit: Thousand (K) dollars
Revenue Breakdown
Belbuca
Jornay Pm
Xtampza ER
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenues, net
199,878
193,520
205,449
209,361
Cost of product revenues (excluding intangible asset amortization)
26,633
20,801
21,598
24,717
Intangible asset amortization and impairment
-
-
-
55,473
Intangible asset amortization
62,953
55,473
55,473
-
Total cost of product revenues
89,586
76,274
77,071
80,190
Gross profit
110,292
117,246
128,378
129,171
Selling, general and administrative
106,594
86,350
67,640
67,103
Gain on fair value remeasurement of contingent consideration
0
0
-19
-19
Total operating expenses
106,594
86,350
67,621
67,084
Income from operations
3,698
30,896
60,757
62,087
Interest expense
19,519
15,862
19,292
21,767
Interest income
2,289
3,706
3,565
3,116
Loss on extinguishment of debt
-
-
-15,994
-
(loss) income before income taxes
-13,532
18,740
29,036
43,436
Provision for income taxes
1,519
4,244
12,073
11,929
Net (loss) income
-15,051
14,496
16,963
31,507
Basic EPS
-0.46
0.45
0.536
1
Diluted EPS
-0.46
0.4
0.357
0.84
Basic Average Shares
32,460,783
32,087,472
31,649,955
31,571,410
Diluted Average Shares
32,460,783
40,065,665
47,451,026
39,439,890
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Belbuca
$57,669K
(9.64%↑ Y/Y)
Jornay Pm
$46,058K
(41.17%↑ Y/Y)
Xtampza ER
$45,006K
Nucynta ER
$15,723K
Nucynta IR
$14,356K
Azstarys
$12,910K
Symproic
$3,020K
(-18.86%↓ Y/Y)
Nucynta ERAG
$2,775K
Nucynta IRAG
$2,361K
Product revenues, net
$199,878K
(6.32%↑ Y/Y)
Net (loss) income
-$15,051K
(-225.60%↓ Y/Y)
Gross profit
$110,292K
(1.76%↑ Y/Y)
Total cost of product
revenues
$89,586K
(12.52%↑ Y/Y)
(loss) income before
income taxes
-$13,532K
(-179.48%↓ Y/Y)
Provision for income taxes
$1,519K
(-69.87%↓ Y/Y)
Income from operations
$3,698K
(-89.47%↓ Y/Y)
Interest income
$2,289K
(-3.94%↓ Y/Y)
Total operating
expenses
$106,594K
(45.46%↑ Y/Y)
Intangible asset
amortization
$62,953K
Cost of product
revenues (excluding...
$26,633K
(10.31%↑ Y/Y)
Interest expense
$19,519K
(-4.61%↓ Y/Y)
Selling, general and
administrative
$106,594K
(44.76%↑ Y/Y)
Buy us a coffee
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)